The FDA has approved Blujepa (gepotidacin), a first-in-class oral antibiotic for uncomplicated urinary tract infections (uUTIs) in women and children aged 12 and older. Clinical trials showed its ...
Nifty MidSmallcap400 Momentum Quality 100 is composed of 100 carefully selected stocks, representing a diverse range of companies. This diverse composition ensures comprehensive m ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback